Zimmer Biomet Holdings, Inc.
Bear Case (25th pct.)
-36.2% vs price
Base Case (Median)
-6.9% vs price
Bull Case (75th pct.)
17.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $15.73 | -84.0% | High (40%) |
| PE Comparable | $91.47 | -6.9% | Medium (25%) |
| Growth Trajectory DCF | $118.17 | 20.3% | Medium (20%) |
| Graham Number | $77.01 | -21.6% | Medium (40%) |
| EV/EBITDA | $111.99 | 14.0% | Medium (20%) |
| EV/FCF | $184.85 | 88.2% | Medium (20%) |
| Earnings Power Value | $48.21 | -50.9% | Medium (50%) |
Based on 7 out of 8 methods, ZBH appears fairly valued at the current price of $98.20. The base case fair value of $91.47 implies 6.9% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.